Ved 7. måned var GMSs henholdsvis 3559, 2 mIU/ ml og 933, 0 mIU/ ml i Fendrix og kontrolgruppen, som modtog en kommercielt tilgængelig hepatitis B vaccine, mens henholdsvis 83, 1% og 67, 5% af personerne havde anti- HB antistoftiter ≥ 100 mIU/ ml.
At month 7, GMTs were 3559.2 mIU/ ml and 933.0 mIU/ ml in the Fendrix and control groups who received the commercially available hepatitis B vaccine respectively, with 83.1% and 67.5% of subjects with anti-HBs antibody titres ≥ 100 mIU/ ml respectively.